Effects of Olanzapine–Fluoxetine Combination Treatment of Major Depressive Disorders on the Quality of Life During Acute Treatment Period

详细信息    查看全文

• 作者：Wei Qu (1)
  Shanshan Gu (1)
  Han Luo (1)
  Qianying Tang (1)
  Junwei Guo (1)
  
• 关键词：Major depressive disorder ; Acute period ; Olanzapine–fluoxetine combination ; Quality of life
• 刊名：Cell Biochemistry and Biophysics
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：70
• 期：3
• 页码：1799-1802
• 全文大小：153 KB
• 参考文献：1. Zhang, M.-Y., & Xiao, Y.-P. (1983). / Textbook of psychiatry (translated), 5th edn. (p. 638). Beijing: People’s Medical Publishing House. Chinese, 2010, pp. 290-13.
  2. Dube, S. W., Andersen, M., & Tohen, E. (2004). Onset of action olanzapine-fluxetine combination for bipolar depression. / Behavioural Brain Research, / 30(7), 202.
  3. Dube, S. W., Andersen, D., & Clemow, N. (2002). Olanzapine-fluoxetine combination for treatment of psychotic depression. / Psychosomatics, / 13(3), 130.
  4. Pigott, T. A., et al. (2009). Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder. / Contemporary Clinical Trials, / 30(3), 205-11. CrossRef
  5. David, J. G., Yily, L. M., & Michael, J. D. (2004). Effects of duloxetine on painful physical symptoms associated with depression. / Psychosomatics, / 45(2), 17-8.
  6. David, G. S., Deborah, Q., & Paul, G. (2008). A randomized, controlled trial of duloxetine alone vs. duloxetine plus a telephone intervention in the treatment of depression. / Journal of Affective Disorders, / 108(7), 33-1.
  7. Michael, J. D., Curtis, G. W., & Craig, H. M. (2004). Duloxetine in the acute and long-term treatment of major depressive disorder: A placebo and paroxetine-controlled trial. / European Neuropsychopharmacology, / 14(3), 457-70.
  8. Chinese Medical Association. (2005). / Scale manual of behavior medicine (pp. 225-26, 485-89). Beijing: Chinese Medical Electronic Audio and Video Publishing House.
  9. Zhang, M.-Y. (1993). / Psychiatric rating scale manual (pp. 150-53). Hunan: Hunan Science and Technology Publishing House.
  
• 作者单位：Wei Qu (1)
  Shanshan Gu (1)
  Han Luo (1)
  Qianying Tang (1)
  Junwei Guo (1)
  
  1. Clinical Psychology Department, Southwest Hospital, Chongqing, 400038, China
  
• ISSN：1559-0283

文摘

The objective of the study was to explore the effects of olanzapine–fluoxetine combination (OFC) treatment of major depressive disorders on the quality of life in the acute treatment period. Methods were prospective and observational design. One hundred and three patients of major depressive disorders were observed. One group of 53 patients received OFC treatment (OFC group); the other group of 50 patients received the treatment of duloxetine (duloxetine group). Two groups were needed to be observed 8?weeks. Observed indicators were Hamilton Depression Rating Scale for Depression (HAMD-24) and four factor scores: the slow, sleep disorders, anxiety/somatization, and hopelessness, Clinical Global Impression-Severity of Illness (CGI-S), WHO quality of life scale (WHOQOL-BREF), and sub-rate measurements. HAMD-24 and four factor scores observation time were assessed before and after treatment; 1, 2, 4, 8?weeks, WHOQOL-BREF score, and sub-time measurements were assessed before treatment and 8?weeks after treatment. HAMD-24 scores of OFC patients in the first week were significantly lower than those of the duloxetine group. The sleep factor scores of OFC patients were significantly lower than those of the duloxetine group in 4 and 8?weeks. By the end of 8?weeks, OFC group was rated significantly lower than the duloxetine group in the physical area. In the acute treatment period, OFC treatment effected faster than the single duloxetine in patients with major depressive disorders. OFC effected within 1?week and was better than the single duloxetine in improving the sleep and physical conditions.